Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
All right. Good morning, everyone. My name is Cory Kasimov. I'm the senior large-cap biotech analyst at JPMorgan, and it's my pleasure to be hosting the next session here. And instead of a standard presentation, we're doing a little fireside chat without the fire. And doing it -- it's really a pleasure to be doing this with Vertex. And it's a good time to be doing it with the transition that's taking place between Jeff and Reshma. But -- so we'll go through a list of questions here. I may also remind everybody that we are not having a breakout session. So this is in lieu of a breakout session, just to make sure no one is running to the room across the hall and fighting the lunch crowd.
And with that, maybe I'll turn it over first to Jeff to make some introductory remarks.
Yes. Thank you, Cory. It's always good to start our year here at JPMorgan with you. It's sort of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
